GlaxoSmithKline Pharmaceuticals Limited CC-Dec24.pdf · 2025-02-14
So, my question was how do we actually look at your business in a slightly longer term over the next 3 years? So, what I can see is that you have your older brand s, which continue to be to do reasonably well. They're growing in line of faster than the market. They're all well -established brands. And then there's a whole slew of new products which are getting added. Do you see this as becoming bigger? And is there something which is, you know, is there an underlying factor here that is the nature of the market itself changing as the country gets richer and there's a bit of a greater willingness to pay for some of the drugs or vaccines which were not available in the country. Could you just give us a sense of as to how you see the market itself evolving?
And what will happen to your margins? Because we have seen margins improve d this year and is that likely to continue and therefore how much scope is there for margins to go up in future?